Some limited evidence indicates that
phenytoin levels may be markedly increased by
sulfinpyrazone. Fosphenytoin, a prodrug of
phenytoin, may interact similarly.
Warn the patient to monitor for indicators of
phenytoin toxicity (blurred vision, nystagmus, ataxia or drowsiness). It would seem advisable to monitor
phenytoin levels.